Welcome to The Visible Embryo

Home-- -History-- -Bibliography- -Pregnancy Timeline- --Prescription Drugs in Pregnancy- -- Pregnancy Calculator- --Female Reproductive System- -Contact

Welcome to The Visible Embryo, a comprehensive educational resource on human development from conception to birth.

The Visible Embryo provides visual references for changes in fetal development throughout pregnancy and can be navigated via fetal development or maternal changes.

The National Institutes of Child Health and Human Development awarded Phase I and Phase II Small Business Innovative Research Grants to develop The Visible Embryo. Initally designed to evaluate the internet as a teaching tool for first year medical students, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than one million visitors each month.

Today, The Visible Embryo is linked to over 600 educational institutions and is viewed by more than 1 million visitors each month. The field of early embryology has grown to include the identification of the stem cell as not only critical to organogenesis in the embryo, but equally critical to organ function and repair in the adult human. The identification and understanding of genetic malfunction, inflammatory responses, and the progression in chronic disease, begins with a grounding in primary cellular and systemic functions manifested in the study of the early embryo.

WHO International Clinical Trials Registry Platform

The World Health Organization (WHO) has created a new Web site to help researchers, doctors and
patients obtain reliable information on high-quality clinical trials. Now you can go to one website and search all registers to identify clinical trial research underway around the world!




Pregnancy Timeline

Prescription Drug Effects on Pregnancy

Pregnancy Calculator

Female Reproductive System

Contact The Visible Embryo

News Alerts Archive

Disclaimer: The Visible Embryo web site is provided for your general information only. The information contained on this site should not be treated as a substitute for medical, legal or other professional advice. Neither is The Visible Embryo responsible or liable for the contents of any websites of third parties which are listed on this site.
Content protected under a Creative Commons License.

No dirivative works may be made or used for commercial purposes.

Return To Top Of Page
Pregnancy Timeline by SemestersFetal liver is producing blood cellsHead may position into pelvisBrain convolutions beginFull TermWhite fat begins to be madeWhite fat begins to be madeHead may position into pelvisImmune system beginningImmune system beginningPeriod of rapid brain growthBrain convolutions beginLungs begin to produce surfactantSensory brain waves begin to activateSensory brain waves begin to activateInner Ear Bones HardenBone marrow starts making blood cellsBone marrow starts making blood cellsBrown fat surrounds lymphatic systemFetal sexual organs visibleFinger and toe prints appearFinger and toe prints appearHeartbeat can be detectedHeartbeat can be detectedBasic Brain Structure in PlaceThe Appearance of SomitesFirst Detectable Brain WavesA Four Chambered HeartBeginning Cerebral HemispheresFemale Reproductive SystemEnd of Embryonic PeriodEnd of Embryonic PeriodFirst Thin Layer of Skin AppearsThird TrimesterSecond TrimesterFirst TrimesterFertilizationDevelopmental Timeline
CLICK ON weeks 0 - 40 and follow along every 2 weeks of fetal development
Google Search artcles published since 2007

Home | Pregnancy Timeline | News Alerts |News Archive Sep 2, 2013


Hutchinson-Gilford Progeria Syndrome (HGPS) is a childhood disorder
caused by mutations in one of the major architectural proteins of the
cell nucleus—identifed in recent 2013 articles as the lamina protein
surrounding the nucleus.

In HGPS patients the cell nucleus has dramatically aberrant
morphology (bottom, right) rather than the uniform shape
typically found in healthy individuals (top, right).

After a period of near perfect renewal (in humans, between 20 and 35 years of age),
organismal senescence is characterised by the declining ability to respond to stress,
increasing homeostatic imbalance and increased risk of disease.
This currently irreversible series of changes inevitably ends in death.

Some researchers (specifically biogerontologists) are treating ageing
as a disease. As genes that have an effect on ageing are discovered,
ageing is increasingly being regarded in a similar fashion to other
geneticly influenced "conditions", as potentially "treatable".

Image Source: Wikipedia

WHO Child Growth Charts




Progeria, cell senescence, and aging

Penn study links epigenetics, aging, and mutations in nuclear proteins to create a better understanding of cancer and rare disorders.

Senescence is the state or process of ageing. Cellular senescence is a phenomenon where isolated cells demonstrate a limited ability to divide in culture.

One way cells promote tumor suppression is through a process called senescence, the end of cell proliferation.

Senescence is associated with normal aging, but is also a protective measure the body uses against run-away cell replication, as in a tumor.

Studying the basic science of senescence gives biomedical research an understanding of mechanisms behind age-related diseases—cancer being one.

The lamina, a network of proteins lining the inside of the membrane of the nucleus, provides support to the shape of the nucleus. It also regulates DNA replication by making some areas of the genome less restricted or more available (permissive) to be translated into proteins. In the case of silencing (turning off) genes, the proteins of the lamina do so by tightening connections between parts of the chromatin and the nuclear membrane, thererby restricing the unraveling of histone proteins.

Researchers from the Perelman School of Medicine at the University of Pennsylvania have found that epigenetic factors play a role in senescence by acting on the chromatin structures in which genes reside. Senescent cells appear to undergo changes in their chromatin similar to changes in cells that are prematurely aging.

These changes take place deep inside the nucleus where DNA winds around proteins called histones. Histone enzymes mark the chromatin – much like sticky notes mark book chapters – to open up or close down regions of a gene. Opening up a gene makes it more available to be “read” or "expressed." Epigenetics is the science of how gene activity can be altered by such chemistry without actually changing the sequence of  the DNA molecule.

Shelley Berger, PhD, professor of Cell and Developmental Biology and director of the Penn Epigenetics Program, plus Parisha Shah, PhD, a postdoctoral fellow in the Berger lab, and colleagues, compared differences in the presence of the genome-wide sticky notes (histones) that exist between two lung cell populations, one at the start of proliferation—as a control—and the other at the end of its replication cycle—at senescence.

They found that when a nuclear protein called lamin B1 is deleted in senescent cells, large-scale changes occur in gene expression, and likely in chromatin structure. The team surmised that the loss of lamin B1 caused the changes in the architecture of chromatin that adds to the aging of cells. They report their findings in Genes & Development.

“Senescence is really a balancing act between aging and cancer. While chromatin regulation and downregulation of lamin B1 have been known to be altered during senescence, how the two processes interact has been poorly understood.”

Shelley Berger, PhD, professor of Cell and Developmental Biology and director, Unversity of Pennsylvania Epigenetics Program

Lamin B1 is part of the lamina, a network lining the inside of the membrane of the nucleus. It provides support to the shape of the nucleus and also regulates DNA replication by making some areas of the genome less or more available to be translated into proteins. In order to silence genes, the proteins of the lamina create tight connections between parts of the chromatin and the nuclear membrane.

The Penn team was surprised by the large portion of the genome that changed its chromatin signature in senescence, particularly in the tightly bound laminar regions in the senescent cell population. In fact, nearly 30 percent of the human genome, as measured by changes in the actual sequence of nucleic acid bases, was different between the two cell populations

When comparing gains and losses of two histone modifiers—those molecular sticky notes—the team found remarkable differences in the senescent cells. Differences including large-scale domains of “sticky-note”-enriched histone “mesas” and “sticky-note”-depleted histone “canyons,” graphically reflected in comparisons of histone gains and losses.

Enriched histone “mesas” form at lamin B1-associated areas on chromatin. Additionally, reduction of lamin B1 in proliferating cell populations triggers premature senescence and reflects as chromatin “canyons.”

Fibroblast cells from patients with Hutchinson-Gilford progeria syndrome, caused by a related mutated lamin A protein, also reflected enriched marker “mesas,” suggesting a link between premature chromatin changes and accelerated cell senescence.

This form of progeria is a genetic condition characterized by the dramatic, rapid appearance of aging, starting in childhood.

Other researchers have found that progeria symptoms are delayed in a mouse model of the human syndrome when the mice are engineered to clear all senescent cells via apoptosis, or cell death.

Comparing cells from children with progeria and their symptom-free parents, the team found that progeria cells have increased chromatin “sticky note” mesas in lamina regions not normally marked as mesas. These areas of the genome are called “permissive” chromatin, and are the signature of an aging cell. Progeria parents’ control cells do not have this permissive chromatin areas as compared to their children’s genes.

Shah, the first author on this study, concludes that “our data illustrate profound chromatin reorganization during senescence and suggest that lamin B1 downregulation in senescence is a key trigger of global and local chromatin changes that affect gene expression, aging, and cancer.”

Berger adds that “once we know the chromatin changes that occur during normal aging, then we can compare and study aberrant chromatin alterations that occur in abnormal aging, including human brain degeneration, which is a growing problem in the aging human population.

“What’s more, since many human diseases exponentially increase with age – one obvious example is cancer – the goal of these studies is to provide insight into the relationship between age and mechanisms of age-related disease” says Berger.

Senescence is a stable proliferation arrest, associated with an altered secretory pathway, thought to promote tumor suppression and tissue aging. While chromatin regulation and lamin B1 down-regulation have been implicated as senescence effectors, functional interactions between them are poorly understood. We compared genome-wide Lys4 trimethylation on histone H3 (H3K4me3) and H3K27me3 distributions between proliferating and senescent human cells and found dramatic differences in senescence, including large-scale domains of H3K4me3- and H3K27me3-enriched “mesas” and H3K27me3-depleted “canyons.” Mesas form at lamin B1-associated domains (LADs) in replicative senescence and oncogene-induced senescence and overlap DNA hypomethylation regions in cancer, suggesting that pre-malignant senescent chromatin changes foreshadow epigenetic cancer changes. Hutchinson-Gilford progeria syndrome fibroblasts (mutant lamin A) also show evidence of H3K4me3 mesas, suggesting a link between premature chromatin changes and accelerated cell senescence. Canyons mostly form between LADs and are enriched in genes and enhancers. H3K27me3 loss is correlated with up-regulation of key senescence genes, indicating a link between global chromatin changes and local gene expression regulation. Lamin B1 reduction in proliferating cells triggers senescence and formation of mesas and canyons. Our data illustrate profound chromatin reorganization during senescence and suggest that lamin B1 down-regulation in senescence is a key trigger of global and local chromatin changes that impact gene expression, aging, and cancer.

Co-authors are also from the Institute of Cancer Sciences, University of Glasgow, UK and the Department of Biology, Penn Genome Frontiers Institute.

This work was supported in part by the National Institute on Aging (P01AG031862) and the Ellison Medical Foundation.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2012, Penn Medicine provided $827 million to benefit our community.

Original press release:http://www.uphs.upenn.edu/news/News_Releases/2013/08/berger/